References
- Philip T., Armitage J. O., Spitzer G. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N. Engl. J. Med. 1987; 316: 1493–1498
- Petersen F. B., Appelbaum F. R., Hill R. Autologous marrow transplantation for malignant lymphoma: A report of 101 cases from Seattle. J. Clin. Oncel. 1990; 8: 638–647
- Fermand J. P., Chevret S., Ravaud P. High-dose Chemotherapy and Autologous Blood Stem Cell Transplantation in Multiple Myeloma: Results of a Phase II Trial involving 63 patients. Blood 1993; 82(7)2005–2009
- Gorin N. C., Labopin M., Meloni G. Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. Leukemia 1991; 5: 896–904
- Vose J. M., Bierman P. J., Anderson J. R. Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: Clinical course and patient follow-up. Blood 1992; 80(8)2142–2148
- Arcese W., Goldman J. M., D'Arcangelo E. Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic leukemia. Blood 1993; 82(10)3211–3219
- Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457–481
- Peto R., Pike M. C., Armitage P., Breslow N. E. Design and analysis of randomized clinical trials requiring pro-longed observation of each patient II: Analysis and examples. Br. J. Cancer 1977; 35: 1–39
- Clift R., Goldman I., Gratwohl A., Harowits M. Proposals for standardized reporting of results of bone marrow transplantation for leukemia. Bone Marrow Transplantation 1989; 4: 445–448
- Kennedy M. J., Vogelsang G. B., Jones R. J. Phase I trial of interferon gamma to potentiate cyclosporineinduced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J. Clin. Oncol. 1994; 12(2)249–257
- Hamon M. D., Prentice H. G., Gottlieb D. J. Immunotherapy with interleukin 2 after ABMT in AML. Bone Marrow Transplantation 1993; 11: 399–401
- Giralt S., Escudier S., Katarjian H. Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. N. Engl. J. Med. 1993; 329: 757–761
- Radich J. P., Sanders J. E., Buckner C. D. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens. J. of Clin. Oncel. 1993; 11(2)304–313
- Papadopoulos E. B., Ladanyl M., Emanuel D. Infusion of donor leukocytes to treat epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 1994; 330: 1185–1191
- Porter D. L., Roth M. S., McGarigle C. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N. Engl. J. Med. 1994; 330: 100–106
- Fischer A., Blanche S., Le Bidois J. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N. Engl. J. Med. 1991; 324: 1451–1456
- Press O. W., Eary J. F., Appelbaum F. R. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N. Engl. J. Med. 1993; 329: 1219–1224
- Kwak L. W., Campell M. J., Czerwinski D. K. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N. Engl. J. Med. 1992; 327: 1209–1215
- Solal-Celigny, Lepage E., Brousse N. Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. N. Engl. J. Med. 1993; 329: 1608–1614
- Smalley R. V., Andersen J. W., Hawkins M. J. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma. N. Engl. J. Med. 1992; 327: 1336–1341